

Maiden Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.73 M
- Company Age 34 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.10 Cr
- Satisfied Charges ₹ 12.12 Cr
- Revenue Growth 5.80%
- Profit Growth -353.48%
- Ebitda 23.51%
- Net Worth -7.02%
- Total Assets 29.95%
About Maiden Pharmaceuticals
Maiden Pharmaceuticals Limited (MPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 22 November 1990 and has a history of 34 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.73 M.
The company currently has active open charges totaling ₹2.10 Cr. The company has closed loans amounting to ₹12.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naresh Goyal, Vivek Goyal, and Rakhi serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230DL1990PLC042161
- Company No.
042161
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Nov 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Maiden Pharmaceuticals?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vivek Goyal ![]() | Director | 15-Dec-2016 | Current |
Naresh Goyal ![]() | Director | 01-Nov-2005 | Current |
Rakhi ![]() | Director | 26-Sep-2022 | Current |
Financial Performance of Maiden Pharmaceuticals.
Maiden Pharmaceuticals Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.8% increase. The company also saw a substantial fall in profitability, with a 353.48% decrease in profit. The company's net worth dipped by a decrease of 7.02%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Maiden Pharmaceuticals?
In 2022, Maiden Pharmaceuticals had a promoter holding of 89.11% and a public holding of 10.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Real Drugs Private Limited
Naresh Goyal is a mutual person
- Mg Lifecare Llp
Naresh Goyal is a mutual person
- Dj Biotech Private Limited
Naresh Goyal and Vivek Goyal are mutual person
- Intact Drugs And Pharmaceuticlas Pvt.Ltd.
Naresh Goyal is a mutual person
- Ndl Pythian Council
Naresh Goyal is a mutual person
- Veu Greens Llp
Vivek Goyal is a mutual person
Charges (Loans)
₹2.10 Cr
₹12.12 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.50 Cr
- Others : 0.60 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
18 Jan 2022 | Axis Bank Limited | ₹1.50 Cr | Open |
26 Jul 2021 | Others | ₹6.00 M | Open |
26 Feb 2022 | Others | ₹4.99 Cr | Satisfied |
28 Aug 2002 | Punjab & Sind Bank | ₹4.60 Cr | Satisfied |
28 Aug 2002 | Punjab & Sind Bank | ₹7.50 M | Satisfied |
How Many Employees Work at Maiden Pharmaceuticals?
Unlock and access historical data on people associated with Maiden Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Maiden Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maiden Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Maiden Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Maiden Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Maiden Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge registered on 26 Feb 2022 via Charge ID 100548885 with Others was fully satisfied on 17 Feb 2023.
- Director Appointment
Rakhi was appointed as a Director was appointed as a Director on 26 Sep 2022 & has been associated with this company since 2 years 7 months .
- Charges
A charge with Others of Rs. 4.99 Cr registered on 26 Feb 2022 with Charge ID 100548885 was modified on 22 Apr 2022.
- Charges
A charge registered on 28 Aug 2002 via Charge ID 90054628 with Punjab & Sind Bank was fully satisfied on 21 Apr 2022.
Recent News, Updates & Announcement
- Maiden Pharma denies tampering with tests in probe of cough syrup deaths.
Maiden Pharmaceuticals, linked to cough syrups associated with child deaths in Gambia, denied tampering with test samples or bribing officials. An investigation by the state of Haryana's Food and Drug Administration is probing whether a state drug regulator was bribed to switch samples tested by the Indian government, contradicting WHO findings. .
- Shocked to hear... Maiden Pharma breaks silence on cough syrup deaths in Gambia.
The pharma company said, We are shocked to hear the media reports regarding the deaths and deeply saddened on this incident but we received the official information from our agent at the Gambia on October 5, 2022, and on the subsequent date, World Health Organisation alert was issued against us. .
Frequently asked questions
What is the Incorporation or founding date of Maiden Pharmaceuticals Limited?
Maiden Pharmaceuticals Limited was incorporated on 22 Nov 1990.
What is authorized share capital and paid-up capital of Maiden Pharmaceuticals Limited?
The authorized share capital of Maiden Pharmaceuticals Limited is ₹ 1.00 Cr and paid-up capital is ₹ 5.73 M.
Who are the current board members & directors of Maiden Pharmaceuticals Limited?
Currently 3 directors are associated with Maiden Pharmaceuticals Limited.
- Naresh Kumar Goyal
- Vivek Goyal
- Rakhi
What is the registered address of Maiden Pharmaceuticals Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Maiden Pharmaceuticals Limited is Unit No. 1273 12Th Floor Aggarwal Cyber Plaza 2 Netaji Subash Place, Pitampura India, Delhi, 110034.
What is the corporate identification number (CIN) and company number of Maiden Pharmaceuticals Limited?
The corporate identification number (CIN) of Maiden Pharmaceuticals Limited is U24230DL1990PLC042161 and the company number is 042161 as per Ministry of Corporate Affairs (MCA).
What is the official website of Maiden Pharmaceuticals Limited?
The Official website of Maiden Pharmaceuticals Limited is https://www.maidenpharma.com
What has been the recent revenue trend for Maiden Pharmaceuticals Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Maiden Pharmaceuticals Limited has risen by 5.80%.
What change has been observed in the net worth of Maiden Pharmaceuticals Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Maiden Pharmaceuticals Limited has experienced an downturn of -7.02%.
What are the total open charges for Maiden Pharmaceuticals Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Maiden Pharmaceuticals Limited amount to ₹ 2.10 Cr.
When was the last Balance Sheet of Maiden Pharmaceuticals Limited filed with the ROC?
The most recent Balance Sheet for Maiden Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
BG
Balraj GoelDirectorRG
Roshan GoyalDirectorVG
Vinay GoyalDirectorVK
Vinod KumarDirectorMS
Mahender SharmaDirectorKG
Kapil GoyalDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India